187 related articles for article (PubMed ID: 12777074)
1. Secretory meningiomas.
Colakoğlu N; Demirtaş E; Oktar N; Yüntem N; Islekel S; Ozdamar N
J Neurooncol; 2003 May; 62(3):233-41. PubMed ID: 12777074
[TBL] [Abstract][Full Text] [Related]
2. Secretory meningioma. A distinct subtype of meningioma.
Alguacil-Garcia A; Pettigrew NM; Sima AA
Am J Surg Pathol; 1986 Feb; 10(2):102-11. PubMed ID: 2420220
[TBL] [Abstract][Full Text] [Related]
3. Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.
Tirakotai W; Mennel HD; Celik I; Hellwig D; Bertalanffy H; Riegel T
Neurosurg Rev; 2006 Jan; 29(1):41-8. PubMed ID: 16010579
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of clinical and pathological features of secretory meningiomas].
Li XJ; Zhang HY; Lang ZQ; Wei B; Chen HJ; Bu H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):488-91. PubMed ID: 16761441
[TBL] [Abstract][Full Text] [Related]
5. Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases.
Probst-Cousin S; Villagran-Lillo R; Lahl R; Bergmann M; Schmid KW; Gullotta F
Cancer; 1997 May; 79(10):2003-15. PubMed ID: 9149029
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
[TBL] [Abstract][Full Text] [Related]
8. Secretory meningiomas of the orbit.
Karikari IO; Syed NA; Cummings TJ
Orbit; 2009; 28(6):408-11. PubMed ID: 19929671
[TBL] [Abstract][Full Text] [Related]
9. Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.
Strojan P; Popović M; Jereb B
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):65-73. PubMed ID: 10924973
[TBL] [Abstract][Full Text] [Related]
10. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
11. Expression of the proliferating cell nuclear antigen and clinicopathological features in intracranial meningiomas.
Kim CH; Cheong JH; Bak KH; Kim JM; Oh SJ
J Clin Neurosci; 2001 May; 8 Suppl 1():44-8. PubMed ID: 11386825
[TBL] [Abstract][Full Text] [Related]
12. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic secretory meningioma: a case report.
Ferchichi L; Bellil S; Ben Hammouda K; Bellil K; Mekni A; Bettaieb I; Haouet S; Khaldi MM; Zitouna K; Kchir N
Pathologica; 2006 Apr; 98(2):153-5. PubMed ID: 16929789
[TBL] [Abstract][Full Text] [Related]
14. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas.
Yang SY; Xu GM
J Clin Neurosci; 2001 May; 8 Suppl 1():49-53. PubMed ID: 11386826
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the keratin polypeptides in meningiomas of different types: an immunohistochemical analysis of 463 cases.
Miettinen M; Paetau A
Hum Pathol; 2002 Jun; 33(6):590-8. PubMed ID: 12152157
[TBL] [Abstract][Full Text] [Related]
16. Involvement of disregulated c-myc but not c-sis/PDGF in atypical and anaplastic meningiomas.
Nagashima G; Aoyagi M; Yamamoto S; Wakimoto H; Tamaki M; Yamamoto K; Fujimoto T; Hirakawa K
Clin Neurol Neurosurg; 2001 Apr; 103(1):13-8. PubMed ID: 11311470
[TBL] [Abstract][Full Text] [Related]
17. Novel histopathological classification of meningiomas based on dural invasion.
Murase M; Tamura R; Kuranari Y; Sato M; Ohara K; Morimoto Y; Yoshida K; Toda M
J Clin Pathol; 2021 Apr; 74(4):238-243. PubMed ID: 32546547
[TBL] [Abstract][Full Text] [Related]
18. Secretory meningiomas: clinical and immunohistochemical observations.
Buhl R; Hugo HH; Mihajlovic Z; Mehdorn HM
Neurosurgery; 2001 Feb; 48(2):297-301; discussion 301-2. PubMed ID: 11220371
[TBL] [Abstract][Full Text] [Related]
19. Secretory meningiomas: a benign subgroup causing life-threatening complications.
Regelsberger J; Hagel C; Emami P; Ries T; Heese O; Westphal M
Neuro Oncol; 2009 Dec; 11(6):819-24. PubMed ID: 19066343
[TBL] [Abstract][Full Text] [Related]
20. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
